March 8

6 Patients were treated, 3 of them foreigners, form Aruba (South America), Angola and Netherlands, completing 1368 patients treated, today March 8, 2018.

The last patient (80) of the clinical trial, approved by Clinical Trials of EUA, was treated today.

The Clinical Trial started on September 1, 2014and finished the recruitment today, March 8, 2018 was very difficult.

Despite our efforts contacting the Association and Urology College, the Association of family physicians and personally several doctors, we dis not received any patient from these colleagues, although the study had no cost to patients.

This is the big study that all doctors are waiting, because it will demonstrate that patients improvement because it, is effective and not by the placebo effect. Patients were selected according to criteria imposed by the Clinical Trials.

On the day of the exam they opened an envelope, whose content they only had knowledge after 6 months.

In the meantime they made tests at 1, 3 and 6 months. Half of the patients was right then submitted to the treatment and the rest only after 6 months, all of them was placed a catheter, however, those of the placebo group nothing was done to them, and therefore they have not improved.

The Clinical Trial only will end in one year, because patients have to do tests periodically for 1 year

With the publication of the results of the Study, whose recruitment and treatment ends today, there will be no doubt that the embolization of the prostatic arteries, for the treatment of benign prostatic hyperplasia, of which we are the world pioneers, is effectively sucessfull and with minimum risks, under local anesthesia and ambulatory.

Next day, the patients from Aruba and Netherlands, Very well